Top

Published in:

01-10-2013 | Original Paper

Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption

Authors: Sven Haller, Logos Curtis, Maryse Badan, Séverine Bessero, Mara Albom, Fabrice Chantraine, Alessandro Alimenti, Karl-Olof Lovblad, Panteleimon Giannakopoulos, Marco Merlo

Published in: Brain Topography | Issue 4/2013

Abstract

Cannabis consumption is temporally associated with the development of first episode psychosis (FEP). Whether or not the chronic use of this substance induces structural brain changes that may be responsible for the cognitive and psychological disturbances in this disorder is still matter of debate. To address this issue, we compared the magnetic resonance imaging (MRI)-assessed grey (GM) and white matter (WM) changes in young FEP patients between users versus non-users of cannabis. This prospective study included 50 consecutive FEP subjects: 33 users (22.7 ± 4.1 years, 4 women) and 17 non-users (23.9 ± 4.2 years, 10 women). Users were further divided into 15 heavy (23.3 ± 4.5 years, 2 women) and 18 light users (22.2 ± 3.8 years, 2 women) according to their lifetime cannabis use. Voxel-based-morphometry (VBM) analysis of GM and tract-based-spatial-statistics (TBSS) analysis of WM were performed. Age and gender were used as non-explanatory co-regressors. There were no supra-threshold differences between user and non-user groups for both GM and WM parameters. This was also the case when only heavy users were compared to non-users. Multivariate models controlling for age and gender confirmed these findings. We found no evidence for cannabis consumption related alterations in GM or WM in FEP subjects. Due to the strict correction for multiple comparisons and sample size, we cannot formally exclude subtle morphometric changes associated with cannabis consumption. However, even if present, such potential alterations would be of low magnitude.

Amminger GP, Harris MG, Conus P, Lambert M, Elkins KS, Yuen HP, McGorry PD (2006) Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatr Scand 114:337–345PubMedCrossRef

Ashburner J, Friston KJ (2000) Voxel-based morphometry: the methods. Neuroimage 11:805–821PubMedCrossRef

Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS (2008) Cannabis use and brain structural alterations in first episode schizophrenia: a region of interest, voxel based morphometric study. Schizophr Res 99:1–6PubMedCrossRef

Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, Johnston P, Baker A, Schall U (2011) Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Int J Neuropsychopharmacol 4:1–11

Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, de Haan L (2010) Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Res 181:51–56PubMedCrossRef

Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S, Russo M, Paparelli A, Butt A, Stilo SA, Wiffen B, Powell J, Murray RM (2009) High-potency cannabis and the risk of psychosis. Br J Psychiatry 195:488–491PubMedCrossRef

Dufton BD, Siddique CM (1992) Measures in the day hospital. I. The global assessment of functioning scale. Int J Partial Hosp 8:41–49PubMed

Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C (2009) Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108:104–113PubMedCrossRef

Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, Mc Guire P, Sacchetti E (2011) Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 35:1175–1185PubMedCrossRef

Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64:774–781PubMedCrossRef

Habets P, Marcelis M, Gronenschild E, Drukker M, van Os J (2011) Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry 69:487–494PubMedCrossRef

Henquet C, Murray R, Linszen D, van Os J (2005) The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31:608–612PubMedCrossRef

Hermann D, Schneider M (2012) Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. Curr Pharm Des 18:4897–4905PubMedCrossRef

Ho BC, Wassink TH, Ziebell S, Andreasen NC (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128:66–75PubMedCrossRef

Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162:2233–2245PubMedCrossRef

James A, Hough M, James S, Winmill L, Burge L, Nijhawan S, Matthews PM, Zarei M (2011) Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res 128:91–97PubMedCrossRef

Kyriakopoulos M, Frangou S (2009) Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 22:168–176PubMedCrossRef

Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T (2012) Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci 263(1):3–13PubMedCrossRef

Martin-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P (2010) Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 40:383–398PubMedCrossRef

Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319–328PubMedCrossRef

Navari S, Dazzan P (2009) Do antipsychotic drugs affect brain structure? a systematic and critical review of MRI findings. Psychol Med 39:1763–1777PubMedCrossRef

Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113PubMedCrossRef

Peters BD, de Haan L, Vlieger EJ, Majoie CB, den Heeten GJ, Linszen DH (2009) Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? Psychopharmacol Bull 42:75–88PubMed

Potvin S, Mancini-Marie A, Fahim C, Mensour B, Levesque J, Karama S, Beauregard M, Rompre PP, Stip E (2007) Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Res 154:275–279PubMedCrossRef

Quickfall J, Crockford D (2006) Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18:318–332PubMedCrossRef

Rais M, Cahn W, Van Haren N, Schnack H, Caspers E, Hulshoff Pol H, Kahn R (2008) Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 165:490–496PubMedCrossRef

Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2010) Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur Neuropsychopharmacol 20:855–865PubMedCrossRef

Rapp C, Bugra H, Riecher-Rossler A, Borgwardt S (2012) Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post-mortem studies. Curr Pharm Des 18(32):5070–5080PubMedCrossRef

Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511–2518PubMedCrossRef

Schnell T, Kleiman A, Gouzoulis-Mayfrank E, Daumann J, Becker B (2012) Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL. Schizophr Res 138(2–3):183–187PubMedCrossRef

Semple DM, McIntosh AM, Lawrie SM (2005) Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 19:187–194PubMedCrossRef

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rossler A, Borgwardt SJ (2009) The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? a systematic review. Curr Pharm Des 15:2535–2549PubMedCrossRef

Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83–98PubMedCrossRef

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–S219PubMedCrossRef

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487–1505PubMedCrossRef

Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, Robson MD, Jones DK, Klein JC, Bartsch AJ, Behrens TE (2007) Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2:499–503PubMedCrossRef

Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, Betensky JD, Lencz T, Ashtari M, Kane JM, Malhotra AK, Gunduz-Bruce H, Napolitano B, Bilder RM (2007) Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry 190:230–236PubMedCrossRef

Wechsler D (1981) Adult Intelligence Scale, revised (WAIS-R). Psychological Corporation, San Antonio, TX

Wobrock T, Sittinger H, Behrendt B, D’Amelio R, Falkai P (2009) Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci 259:28–36PubMedCrossRef

Zimmerman P, Fimm B (1994) Tests d’evaluation de l’attention (TEA) (Version 1.02, française). Psytest, Wu¨rselen

Title: Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption
Authors: Sven Haller
Logos Curtis
Maryse Badan
Séverine Bessero
Mara Albom
Fabrice Chantraine
Alessandro Alimenti
Karl-Olof Lovblad
Panteleimon Giannakopoulos
Marco Merlo
Publication date: 01-10-2013
Publisher: Springer US
Published in: Brain Topography / Issue 4/2013
Print ISSN: 0896-0267
Electronic ISSN: 1573-6792
DOI: https://doi.org/10.1007/s10548-013-0288-8

At a glance: The STEP trials

Springer Medicine

Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Negative BOLD Response to Interictal Epileptic Discharges in Focal Epilepsy

MEG Measures of Covert Orienting and Gaze Processing in Children

Electrophysiological Correlates of Processing Own- and Other-Race Faces

Independent Sources of Spontaneous BOLD Fluctuation Along the Visual Pathway

A Reliable Statistical Method to Detect Eyeblink-Artefacts from Electroencephalogram Data Only

Separation of Low-Voltage EEG-Activity During Mental Activation from that During Transition to Drowsiness